MH
Therapeutic Areas
TopAlliance Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| LOQTORZI (Toripalimab) | Nasopharyngeal Carcinoma (and other undisclosed oncology indications) | Approved |
| Undisclosed ADC Programs | Oncology | Not Disclosed |
| Drug | Indication | Phase |
|---|---|---|
| LOQTORZI (Toripalimab) | Nasopharyngeal Carcinoma (and other undisclosed oncology indications) | Approved |
| Undisclosed ADC Programs | Oncology | Not Disclosed |